Literature DB >> 24760107

Anterior and intermediate pituitary tissues express claudin 4 in follicle stellate cells and claudins 2 and 5 in endothelial cells.

Alejandro García-Godínez1, Rubén Gerardo Contreras, Margarita González-Del-Pliego, Elsa Aguirre-Benítez, Isabel Acuña-Macías, M Teresa de la Vega, Dolores Martín-Tapia, Carmen Solano-Agama, M Eugenia Mendoza-Garrido.   

Abstract

Follicle-stellate cells are pituitary non-granular cells that are arranged between secretory cells or organized in follicles with small lumens. Cells from the follicles exhibit the typical phenotype of a transporting epithelium, including apical microvilli with a cilium and tight junctions. Freeze-fracture electron microscopy images show that the tight junctions consist of 5-7 anastomosing strands and that cultured follicle-stellate cells develop a trans-epithelial electrical resistance characteristic of "tight" epithelia. Here, we investigate the molecular composition of the tight junction from follicle stellate cells. We found that the rat anterior pituitary lobe expresses mRNAs for claudins 2, 4 and 5; the proteins of all these claudins are observed in the anterior lobe, whereas the intermediate lobe expresses claudins 2 and 5 and the posterior lobe contains only claudin 5. Follicle-stellate cells, identified by their protein marker S100β, expresses claudin 4 in the apical membrane, in co-localization with dipeptidyl-peptidase and near acetylated β-tubulin. Claudin 4 partially co-localizes with E-cadherin, indicating that a fraction of the protein is located in the basolateral domain. Follicle-stellate-enriched cell cultures develop patches of polygonal cells expressing claudin 4 and E-cadherin, encircled by extensive monolayers of fusiform cells. Claudin 2 stains specifically blood vessels, identified by claudin 5 and VE-cadherin labels. Thus, follicles in the anterior pituitary consist of "tight" epithelia that can carry out intense vectorial transport, together with a high cation movement in blood vessels, possibly related to the ion requirements of excitable secretory cells for hormone secretion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760107     DOI: 10.1007/s00441-014-1827-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  5 in total

1.  Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel.

Authors:  Christopher Breed; Douglas A Hicks; Patricia G Webb; Carly E Galimanis; Benjamin G Bitler; Kian Behbakht; Heidi K Baumgartner
Journal:  Mol Cancer Res       Date:  2019-01-03       Impact factor: 5.852

2.  Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer.

Authors:  Artur Mezheyeuski; Carina Strell; Ina Hrynchyk; Tormod Kyrre Guren; Anca Dragomir; Tatyana Doroshenko; Oksana Pashkova; Julia Gorgun; Kseniya Ruksha; Per Pfeiffer; Elin H Kure; Halfdan Sorbye; David Edler; Anna Martling; Bengt Glimelius; Arne Östman; Anna Portyanko
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

3.  Claudin-9 constitutes tight junctions of folliculo-stellate cells in the anterior pituitary gland.

Authors:  Atsuko Y Higashi; Tomohito Higashi; Kyoko Furuse; Kana Ozeki; Mikio Furuse; Hideki Chiba
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

4.  Expression and localization of tight junction-related proteins in adult rat pituitary stem/progenitor cell niches.

Authors:  Saishu Yoshida; Hideaki Yurino; Masaaki Kobayashi; Naoto Nishimura; Kentaro Yano; Ken Fujiwara; Shin-Ichi Hashimoto; Takako Kato; Yukio Kato
Journal:  J Reprod Dev       Date:  2022-04-12       Impact factor: 2.215

5.  Cell Type- and Sex-Dependent Transcriptome Profiles of Rat Anterior Pituitary Cells.

Authors:  Patrick A Fletcher; Kosara Smiljanic; Rafael Maso Prévide; James R Iben; Tianwei Li; Milos B Rokic; Arthur Sherman; Steven L Coon; Stanko S Stojilkovic
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.